Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-Pass Intestinal Perfusion (SPIP) Method
Document Type
Article
Publication Title
Current Pharmaceutical Analysis
Publication Date
1-1-2024
Abstract
Introduction: Antiretroviral medications are widely used to treat HIV infections. Lamivudine (3TC) is prescribed for HIV-1 infection management in adults and pediatrics, while valganciclovir (VGC) is a prodrug of ganciclovir derived from valine. Methods: The Biopharmaceutics Classification System (BCS) estimates the contributions of intestinal permeability, dissolution, and solubility in oral drug absorption. Intestinal permeability refers to a substance's capacity to pass through the protective layer of cells in the intestine. The intestinal permeability of 3TC and VGC was analyzed and categorized using the single-pass intestinal perfusion technique according to the BCS in male Sprague Dawley rats, and a reversed-phase HPLC method was validated for precise and accurate measurement. Results: According to the BCS, 3TC and VGC have been classified as having low permeability when compared to metoprolol tartrate, which is classified as Class I with good permeability and resolution. Conclusion: The permeability values derived from this work can be valuable in exposure assessment models.
Volume
20
Issue
7
First Page
585
Last Page
596
DOI
10.2174/0115734129310868240805065851
Recommended Citation
Şanlı, S., Kaynak, M., Şanlı, N., & Balta, E. (2024). Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-Pass Intestinal Perfusion (SPIP) Method. Current Pharmaceutical Analysis, 20 (7), 585-596. https://doi.org/10.2174/0115734129310868240805065851
ISSN
15734129
E-ISSN
1875676X